Spotify Stock Surges 15% on Long-Term Growth Targets and New Premium Features
Mondeum Capital (UK) Limited
Spotify shares had their best day in almost seven years, climbing 15% on Thursday. The jump came after the company’s investor day, where Spotify shared long-term revenue and margin goals to give investors a clearer picture of its plans. These specific commitments sparked new interest in the stock after a stretch of weaker performance.
Co-CEOs Gustav Soderstrom and Alex Norstrom also shared clear financial goals through 2030. Spotify aims for annual revenue growth in the mid-teens, gross margins between 35% and 40%, and operating margins above 20%. The company expects strong growth in free cash flow as well. Spotify’s bigger goals include reaching 1 billion subscribers, €100 billion in revenue, and gross margins over 40%.
Spotify also announced two new premium features at the investor day. The first is an AI tool, made with Universal Music Group, that lets Premium subscribers create covers and remixes of songs for an extra fee. The second feature, called Reserved, finds an artist’s biggest fans and holds two concert tickets for them. These features will start rolling out this summer for some new tours.
These announcements come about a month after Spotify’s first-quarter earnings report, which showed subscriber growth was below Wall Street’s expectations. For this quarter, Spotify expects to add 6 million premium subscribers, reaching a total of 299 million, and projects operating income of €630 million. Earlier this year, Spotify raised the price of its U.S. individual premium plan from $11.99 to $12.99.
Even with Thursday’s jump, Spotify’s stock is still down about 15% in 2026 and 36% over the past year.
Featured CoursesRecent news
IMAX Stock Jumps 15% on Sale Reports: Who’s Buying?
IMAX is considering a sale, sparking speculation about buyers. Shares rose 15% Friday after the Wall Street Journal reported IMAX approached entertainment companies. The process is early and may not end in a deal. Here are the analysts’ top buyer picks and what each could gain with IMAX. Netflix is attracting the most attention as […]
Merck Shares Jump 4.9% on Cancer Trial Win as Keytruda Patent Cliff Looms
Merck wants to show it is not just a one-drug company, and Friday’s clinical trial results gave it a boost. Shares rose 4.9% in premarket trading after a partner drug worked well in advanced lung cancer when used with Merck’s main cancer treatment. At the same time, European regulators moved closer to approving another Keytruda […]
Micron Stock Slips 1% After a Volatile Week for Memory Chip Stocks
Micron shares slipped 1% in early Friday trading after a week of ups and downs. The stock climbed from below $660 to a 4.1% gain on Thursday, but then fell back by Friday morning. This week, the memory chip sector was influenced by remarks from a competitor’s CEO, a narrowly avoided strike at Samsung, and […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.